Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pacira Pharmaceuticals | -1.430% | -0.709% | 12.903% | -26.702% | -6.040% | -47.664% | -26.528% |
| Incyte Corp. | -0.230% | 1.567% | 10.158% | -10.809% | -6.345% | -21.738% | -25.937% |
| Celldex Therapeutics | -5.110% | -9.189% | -8.197% | 9.804% | -7.182% | 48.673% | 532.768% |
| Savara Inc. | -3.030% | -8.756% | -8.756% | 69.231% | -8.333% | 202.290% | -59.459% |
| Kala Pharmaceuticals Inc. | - | -0.169% | -1.003% | -61.408% | -9.202% | -97.313% | - |
| Organovo Holdings Inc. | 1.730% | -4.240% | -1.907% | -44.484% | -9.747% | -84.795% | -90.628% |
| TherapeuticsMD Inc. | 2.140% | -1.579% | 8.721% | -53.483% | -10.952% | -96.222% | -98.613% |
| Zoetis Inc. A | -0.300% | -1.126% | 13.137% | -1.421% | -11.069% | 9.463% | 71.851% |
| Champions Oncology Inc | -0.930% | -1.835% | -8.547% | -10.084% | -11.203% | -46.164% | - |
| Repligen Corp. | -0.780% | -6.612% | -8.216% | -7.025% | -12.351% | -0.575% | - |
| Akebia Therapeutics Inc. | -2.400% | -3.890% | -20.921% | -20.983% | -13.567% | -64.580% | - |
| Exelixis Inc. | -0.520% | -3.303% | -13.212% | 5.238% | -13.688% | -5.951% | 2.192% |
| Regenxbio Inc | -4.860% | -2.041% | -2.041% | -22.581% | -13.772% | -50.447% | - |
| Corcept Therapeutics Inc. | -2.340% | 1.618% | 19.767% | 10.043% | -14.167% | 45.480% | - |
| Ultragenyx Pharmaceutical Inc. | -0.520% | -4.592% | -11.374% | -21.757% | -14.220% | -56.512% | -33.641% |
| Biogen Inc. | -0.100% | -4.676% | 11.925% | -28.389% | -14.419% | -13.223% | -1.054% |
| Dynavax Technologies Corp | 1.000% | 5.537% | -0.904% | 6.511% | -14.741% | 73.308% | 95.679% |
| Gilead Sciences Inc | -0.200% | -2.001% | -2.236% | -16.160% | -16.275% | 8.488% | 2.033% |
| Xeris Biopharma Holdings Inc. | -4.240% | -0.826% | 7.914% | -30.233% | -16.667% | -36.886% | - |
| Bristol-Myers Squibb | 0.490% | -5.345% | -16.066% | -37.824% | -17.188% | -30.162% | -8.935% |